Iversun: The Definitive Antiparasitic Treatment for Systemic Infections
| Product dosage: 12mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 100 | $2.51 | $250.78 (0%) | 🛒 Add to cart |
| 200 | $1.76 | $501.56 $351.09 (30%) | 🛒 Add to cart |
| 300 | $1.67
Best per pill | $752.33 $501.56 (33%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Iversun is a highly effective, broad-spectrum antiparasitic medication formulated with the active ingredient Ivermectin. Developed through advanced pharmaceutical research, it targets and eliminates a wide range of parasitic infestations by disrupting neuromuscular function in parasites, leading to their paralysis and death. Trusted by healthcare professionals globally, Iversun offers a reliable solution for patients suffering from conditions such as onchocerciasis, strongyloidiasis, and other helminthic infections. Its well-documented efficacy and favorable safety profile make it a cornerstone in both clinical and public health settings for managing parasitic diseases.
Features
- Contains Ivermectin as the active pharmaceutical ingredient
- Available in 3 mg and 6 mg oral tablet formulations
- Manufactured under strict GMP (Good Manufacturing Practice) standards
- Precisely calibrated dosage for systemic absorption
- Long shelf life with stability under recommended storage conditions
- Packaged in blister packs to ensure integrity and ease of use
Benefits
- Effectively eradicates a broad spectrum of parasitic organisms, reducing morbidity
- Rapid symptomatic relief, often within days of initiation
- Single or short-course dosing enhances patient compliance and treatment adherence
- Reduces transmission rates in endemic areas, contributing to community health
- Minimizes risk of chronic complications associated with untreated parasitic infections
- Well-tolerated by most patient demographics with a low incidence of severe adverse effects
Common use
Iversun is primarily indicated for the treatment of onchocerciasis (river blindness), caused by the parasitic worm Onchocerca volvulus, and intestinal strongyloidiasis due to Strongyloides stercoralis. It is also used off-label under medical supervision for certain ectoparasitic infestations such as scabies, and in combination therapies for lymphatic filariasis. In veterinary medicine, it is employed for heartworm prevention and mange treatment, though human formulations are strictly for human use only under prescription.
Dosage and direction
Dosage is weight-based and must be calculated by a healthcare provider. For onchocerciasis: a single oral dose of 150 mcg/kg. For strongyloidiasis: a single oral dose of 200 mcg/kg. Tablets should be taken on an empty stomach with a full glass of water to maximize absorption. Dosing may be repeated every 3–12 months for certain conditions, as determined by a physician. Do not crush or chew tablets; swallow whole.
Precautions
Use with caution in patients with hepatic impairment, as metabolism may be altered. Avoid in patients with known hypersensitivity to Ivermectin or any component of the formulation. Not recommended during pregnancy unless potential benefits outweigh risks. Breastfeeding should be discontinued during treatment. May cause dizziness; patients should avoid driving or operating machinery until response is known. Regular monitoring for parasitic load reduction is advised in chronic infections.
Contraindications
Hypersensitivity to Ivermectin or any excipients in the formulation. Meningeal or central nervous system conditions where increased parasite motility could lead to inflammatory reactions (e.g., in loiasis co-infection). Should not be used in children weighing less than 15 kg unless specifically indicated and supervised by a specialist.
Possible side effect
Most side effects are mild and transient. Common reactions include dizziness, nausea, diarrhea, pruritus, and mild skin rash. Less frequently, patients may experience orthostatic hypotension, elevated liver enzymes, or transient eosinophilia. Rare severe reactions include severe skin reactions, hepatitis, or neurological effects such as ataxia. Seek medical attention if symptoms persist or worsen.
Drug interaction
Iversun is metabolized by CYP450 enzymes; coadministration with strong CYP3A4 inhibitors (e.g., ketoconazole) may increase Ivermectin plasma levels. Conversely, inducers like rifampin may reduce efficacy. Use caution with other CNS depressants. No significant interactions with anticoagulants or antiplatelet agents have been documented, but always disclose all medications to your prescriber.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to catch up. For single-dose regimens, contact your healthcare provider for guidance. Adherence to the prescribed schedule is critical for therapeutic success.
Overdose
Symptoms of overdose may include exaggerated side effects such as severe nausea, vomiting, dizziness, and hypotension. In extreme cases, neurological symptoms like confusion or coma may occur. There is no specific antidote; treatment is supportive and symptomatic. Gastric lavage or activated charcoal may be considered if ingestion was recent. Contact poison control or seek emergency medical attention immediately.
Storage
Store at room temperature (15–30°C) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused medication properly according to local regulations; do not flush or pour into drains.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or changing your treatment plan. The manufacturer is not liable for misuse or incorrect application of this product.
Reviews
“After years of struggling with recurrent strongyloidiasis, Iversun provided complete resolution with just one dose. Minimal side effects and excellent tolerance.” — Dr. Elena M., Infectious Disease Specialist
“As a public health worker in an endemic region, I have witnessed the dramatic reduction in onchocerciasis transmission since incorporating Iversun into our mass drug administration programs.” — Public Health Official, West Africa
“Effective and reliable. I prescribe it confidently knowing the robust evidence behind its use.” — General Practitioner, Southeast Asia